<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report" xml:lang="en">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">BMC Cancer</journal-id>
      <journal-id journal-id-type="iso-abbrev">BMC Cancer</journal-id>
      <journal-title-group>
        <journal-title>BMC Cancer</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1471-2407</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">23164213</article-id>
      <article-id pub-id-type="pmc">3537684</article-id>
      <article-id pub-id-type="publisher-id">1471-2407-12-531</article-id>
      <article-id pub-id-type="doi">10.1186/1471-2407-12-531</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Germline truncating-mutations in <italic>BRCA1</italic> and <italic>MSH6</italic> in a patient with early onset endometrial cancer</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="yes" id="A1">
          <name>
            <surname>Kast</surname>
            <given-names>Karin</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>karin.kast@uniklinikum-dresden.de</email>
        </contrib>
        <contrib contrib-type="author" id="A2">
          <name>
            <surname>Neuhann</surname>
            <given-names>Teresa M</given-names>
          </name>
          <xref ref-type="aff" rid="I2">2</xref>
          <xref ref-type="aff" rid="I3">3</xref>
          <email>neuhann@mgz-muenchen.de</email>
        </contrib>
        <contrib contrib-type="author" id="A3">
          <name>
            <surname>G&#xF6;rgens</surname>
            <given-names>Heike</given-names>
          </name>
          <xref ref-type="aff" rid="I4">4</xref>
          <email>Heike.Goergens@uniklinikum-dresden.de</email>
        </contrib>
        <contrib contrib-type="author" id="A4">
          <name>
            <surname>Becker</surname>
            <given-names>Kerstin</given-names>
          </name>
          <xref ref-type="aff" rid="I2">2</xref>
          <email>kerstin.becker1@mailbox.tu-dresden.de</email>
        </contrib>
        <contrib contrib-type="author" id="A5">
          <name>
            <surname>Keller</surname>
            <given-names>Katja</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>Katja.Keller@uniklinikum-dresden.de</email>
        </contrib>
        <contrib contrib-type="author" id="A6">
          <name>
            <surname>Klink</surname>
            <given-names>Barbara</given-names>
          </name>
          <xref ref-type="aff" rid="I2">2</xref>
          <email>Barbara.Klink@tu-dresden.de</email>
        </contrib>
        <contrib contrib-type="author" id="A7">
          <name>
            <surname>Aust</surname>
            <given-names>Daniela</given-names>
          </name>
          <xref ref-type="aff" rid="I5">5</xref>
          <email>Daniela.Aust@uniklinikum-dresden.de</email>
        </contrib>
        <contrib contrib-type="author" id="A8">
          <name>
            <surname>Distler</surname>
            <given-names>Wolfgang</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>Frauenklinik@uniklinikum-dresden.de</email>
        </contrib>
        <contrib contrib-type="author" id="A9">
          <name>
            <surname>Schr&#xF6;ck</surname>
            <given-names>Evelin</given-names>
          </name>
          <xref ref-type="aff" rid="I2">2</xref>
          <email>Evelin.Schrock@tu-dresden.de</email>
        </contrib>
        <contrib contrib-type="author" id="A10">
          <name>
            <surname>Schackert</surname>
            <given-names>Hans K</given-names>
          </name>
          <xref ref-type="aff" rid="I4">4</xref>
          <email>Hans.Schackert@uniklinikum-dresden.de</email>
        </contrib>
      </contrib-group>
      <aff id="I1"><label>1</label>Department of Gynecology and Obstetrics, University Hospital Carl Gustav Carus, Technische Universit&#xE4;t Dresden, Dresden, Germany</aff>
      <aff id="I2"><label>2</label>Institute for Clinical Genetics, Technische Universit&#xE4;t Dresden, Dresden, Germany</aff>
      <aff id="I3"><label>3</label>Medical Genetic Center, Munich, Germany</aff>
      <aff id="I4"><label>4</label>Department of Surgical Research, University Hospital Carl Gustav Carus, Technische Universit&#xE4;t Dresden, Dresden, Germany</aff>
      <aff id="I5"><label>5</label>Institute of Pathology, University Hospital Carl Gustav Carus, Technische Universit&#xE4;t Dresden, Dresden, Germany</aff>
      <pub-date pub-type="collection">
        <year>2012</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>20</day>
        <month>11</month>
        <year>2012</year>
      </pub-date>
      <volume>12</volume>
      <fpage>531</fpage>
      <lpage>531</lpage>
      <history>
        <date date-type="received">
          <day>22</day>
          <month>6</month>
          <year>2012</year>
        </date>
        <date date-type="accepted">
          <day>8</day>
          <month>11</month>
          <year>2012</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright &#xA9;2012 Kast et al.; licensee BioMed Central Ltd.</copyright-statement>
        <copyright-year>2012</copyright-year>
        <copyright-holder>Kast et al.; licensee BioMed Central Ltd.</copyright-holder>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0">
          <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (
<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0">http://creativecommons.org/licenses/by/2.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <self-uri xlink:href="http://www.biomedcentral.com/1471-2407/12/531"/>
      <abstract>
        <sec>
          <title>Background</title>
          <p>Hereditary Breast and Ovarian Cancer Syndrome (HBOCS) and Hereditary Non-Polyposis Colorectal Cancer Syndrome (HNPCC, Lynch Syndrome) are two tumor predisposition syndromes responsible for the majority of hereditary breast and colorectal cancers. Carriers of both germline mutations in breast cancer genes <italic>BRCA1</italic> or <italic>BRCA2</italic> and in mismatch repair (MMR) genes <italic>MLH1, MSH2, MSH6</italic> or <italic>PMS2</italic> are very rare<italic>.</italic></p>
        </sec>
        <sec>
          <title>Case presentation</title>
          <p>We identified germline mutations in <italic>BRCA1</italic> and in <italic>MSH6</italic> in a patient with increased risk for HBOC diagnosed with endometrial cancer at the age of 46 years.</p>
        </sec>
        <sec>
          <title>Conclusions</title>
          <p>Although carriers of mutations in both MMR and BRCA genes are rare in Caucasian populations and anamnestical and histopathological findings may guide clinicians to identify these families, both syndromes can only be diagnosed through a complete gene analysis of the respective genes.</p>
        </sec>
      </abstract>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>Background</title>
      <p>Hereditary Breast and Ovarian Cancer Syndrome (HBOCS) is an autosomal dominantly inherited disease caused by mutations in <italic>BRCA1</italic> or <italic>BRCA2</italic> and characterized by young age of onset, synchronous or metachronous disease, and a family history of first and second degree relatives with breast and/or ovarian cancer. Depending on the affected gene, the estimated lifetime risks range from 46-85% for breast and 11-53% for ovarian cancer
[<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B2">2</xref>].</p>
      <p>Lynch syndrome (hereditary non-polyposis colorectal cancer, HNPCC), is also an autosomal dominant tumor predisposition caused by germline mutations in DNA mismatch repair (MMR) genes <italic>MLH1, MSH2, MSH6</italic> or <italic>PMS2</italic> with a life-time risk for colorectal cancer (CRC) of up to 80% and considerably increased risk of developing a broad spectrum of extracolonic malignancies including, among others, endometrial cancer (EC), stomach cancer and ovarian cancer
[<xref ref-type="bibr" rid="B3">3</xref>,<xref ref-type="bibr" rid="B4">4</xref>]. In females, the cumulative risk for EC is 17-57% and almost equally high for CRC
[<xref ref-type="bibr" rid="B5">5</xref>-<xref ref-type="bibr" rid="B8">8</xref>]. In <italic>MSH6</italic> gene mutation carriers, CRC and ovarian cancer risks are lower
[<xref ref-type="bibr" rid="B9">9</xref>]. However, <italic>MSH6</italic> is only affected in a small fraction of all MMR gene mutation carriers
[<xref ref-type="bibr" rid="B6">6</xref>,<xref ref-type="bibr" rid="B8">8</xref>].</p>
      <p>Little is known about the phenotype of families with double mutations causing both HNPCC and HBOCS. Therefore, we report on a female index patient in a family fulfilling the criteria for HBOCS which developed endometrial cancer at age 46 and was identified as a double heterozygous germline mutation carrier.</p>
    </sec>
    <sec>
      <title>Case presentation</title>
      <p>The index patient of the family (individual III:1) was diagnosed with early stage endometrioid endometrial cancer at the age of 46 years, thus almost meeting the original Bethesda Guideline 4
[<xref ref-type="bibr" rid="B10">10</xref>]. She was referred to our Center for Hereditary Breast and Ovarian Cancer because of the early demise of her sister (III:2) due to triple negative breast cancer at the age of 33 years. Likewise, her mother (II:2) suffered from triple negative breast cancer at the age of 56. Her maternal aunt (II:5) had papillary-serous ovarian cancer at the age of 43 and additionally had been diagnosed with cervical squamous cell carcinoma at the age of 40. Moreover, the patient reported that her maternal grandfather I:1 had died of gastric cancer at the age of 67 years (no histologic or pathologic report were available). Four further maternal aunts and uncles and all of their children had not been reported for malignant diseases. One case of abdominal cancer of unknown origin (II:13) was reported in the paternal pedigree (Figure&#x2009;
<xref ref-type="fig" rid="F1">1</xref>). All family members with breast or ovarian cancer had died. After counseling of the index patient and obtaining informed consent, analysis of the breast cancer genes <italic>BRCA1</italic> and <italic>BRCA2</italic> and testing for HNPCC was performed.</p>
      <fig id="F1" position="float">
        <label>Figure 1</label>
        <caption>
          <p><bold>Pedigree.</bold> The black arrow indicates the index patient and the black dot the unaffected female carrier of the familial <italic>BRCA1</italic> mutation. Documentation was not available for the &#x201C;gastric cancer&#x201D; reported in I:1. Abbreviations: AO- age of onset, mut. &#x2010; mutation, pos. &#x2010; positive, neg. &#x2010; negative.</p>
        </caption>
        <graphic xlink:href="1471-2407-12-531-1"/>
      </fig>
      <p>DNA-analysis of <italic>BRCA</italic> genes <italic>1</italic> and <italic>2</italic> was carried out by pre-screening of DNA extracted from lymphocytes of the index patient (III:1) with DHPLC (Denaturing High Performance Liquid Chromatography) using the WAVE&#xAE; System 2100 (Transgenomic Ltd, United Kingdom) as described elsewhere
[<xref ref-type="bibr" rid="B11">11</xref>]. Sanger sequencing of suspect fragments revealed the pathogenic <italic>BRCA1</italic> mutation c.213-12A&gt;G, p.Arg71SerfsX21. This nucleotide change is predicted to form a cryptic splice site resulting in the addition of 11 nucleotides to the <italic>BRCA1</italic> transcript and a truncated protein
[<xref ref-type="bibr" rid="B12">12</xref>]. Immunohistochemical staining (IHC) of MMR proteins MLH1<italic>,</italic> MSH2<italic>,</italic> MSH6 and PMS2 was carried out on formalin-fixed, paraffin-embedded tumor sections of the endometrial cancer of individual III:1 as described elsewhere
[<xref ref-type="bibr" rid="B13">13</xref>]. Loss of expression of MSH6 was identified. Consequently, sequencing of the <italic>MSH6</italic> gene was performed using primers and conditions described elsewhere
[<xref ref-type="bibr" rid="B14">14</xref>], which revealed the pathogenic mutation c.515_516insT, p.Ile172fsX10.</p>
      <p>The index patient (III:1) was thus identified as a carrier of pathogenic germline mutations in both <italic>BRCA1</italic> and <italic>MSH6</italic>. At the time of counseling she was 51 years of age. The endometrial cancer had been diagnosed at stage pT1a pNx G3 (FIGO IA) and was treated with hysterectomy, bilateral adnexectomy and resection of the upper proximal part of the vagina. Although facing a lifelong estimated risk for breast cancer of up to 80%
[<xref ref-type="bibr" rid="B2">2</xref>] she decided against preventive surgery. In addition to breast cancer surveillance, screening exams for HNPCC-associated tumors according to the German HNPCC Consortium
[<xref ref-type="bibr" rid="B15">15</xref>] have been regularly performed in the last three years without pathological findings.</p>
      <p>Her sister (III:3) and her nieces (IV:5 and IV:6) underwent predictive testing for the <italic>BRCA1</italic> mutation of which IV:5 was identified to be a carrier. The sister (III:3) of the index patient and one niece (IV:5) were tested for the familial <italic>MSH6</italic> mutation and none of them carries the mutation. At the time of writing this article, no further predictive testings have been carried out in other family members.</p>
    </sec>
    <sec sec-type="conclusions">
      <title>Conclusions</title>
      <p>To date, only two families with co-occurrence of a MMR and <italic>BRCA1/BRCA2</italic> mutation have been reported
[<xref ref-type="bibr" rid="B16">16</xref>,<xref ref-type="bibr" rid="B17">17</xref>]. Thiffault et al. described two protein truncating mutations in <italic>MSH2</italic> and <italic>BRCA2</italic> identified in one female individual with breast cancer at the age of 32 and colon polyps at the age of 40. The patient&#x2019;s father (who had died at the age of 36 years) was an obligate carrier of both mutations and had CRC at 32 years. The female patient described by Borg et al. carried two <italic>MLH1</italic> missense mutations (one of which segregating with familial, Lynch syndrome associated tumors) plus a <italic>BRCA1</italic> mutation, being diagnosed with breast cancer at the age of 35 years. The reported tumors in these patients and the hereby reported case do not exceed the spectrum of HBOCS/HNPCC associated malignancies and are within the expected age range of disease onset for carriers of a germline mutation in the respective MMR or BRCA genes alone.</p>
      <p>In our family, the only Lynch syndrome associated malignancy was the EC in the index patient. Although three other cancers in both family branches (I:1, I:2, II:13) have been described, no proof of the tumor origin and/or pathology findings were available. It cannot be determined from the pedigree whether the <italic>MSH6</italic> mutation originates from the maternal or paternal side. Since it is unlikely that the <italic>MSH6</italic> mutation represents a <italic>de novo</italic> mutation, the low frequency of Lynch Syndrome associated cancers in both branches of the family may be due to reduced penetrance of <italic>MSH6</italic> mutations
[<xref ref-type="bibr" rid="B8">8</xref>,<xref ref-type="bibr" rid="B9">9</xref>,<xref ref-type="bibr" rid="B18">18</xref>]. So far, only two members of the family consented for predictive testing for the <italic>MSH6</italic> mutation, none of which carried the mutation.</p>
      <p>No consensus exists regarding the association of breast cancer with Lynch Syndrome. Although MSI has been described in most breast cancers of HNPCC kindreds, the risk for breast cancer is not elevated in most families
[<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B19">19</xref>-<xref ref-type="bibr" rid="B23">23</xref>]. However, a recent prospective study revealed an almost four-fold increase of breast cancer incidence in carriers of a mutation in the HNPCC-genes
[<xref ref-type="bibr" rid="B24">24</xref>]. Moreover, Scott et al. reported on a significant overrepresentation of breast cancers in <italic>MLH1</italic> mutation carriers
[<xref ref-type="bibr" rid="B25">25</xref>].</p>
      <p>Triple negativity has been shown to be strongly associated with mutation carrier status of <italic>BRCA1</italic>[<xref ref-type="bibr" rid="B26">26</xref>]. Thus, two triple negative breast cancers and the presence of an ovarian cancer strongly suggested a <italic>BRCA1</italic>-associated disease in this family (Figure&#x2009;
<xref ref-type="fig" rid="F1">1</xref>). Furthermore, a slightly increased risk for uterine and cervical cancer as well as colorectal cancer has also been reported for <italic>BRCA1</italic> mutation carriers
[<xref ref-type="bibr" rid="B27">27</xref>]. The uterine cancer of III:1 could therefore be misinterpreted as caused by the <italic>BRCA1</italic> germline mutation<italic>.</italic> Nevertheless, HBOCS-associated uterine cancers tend to be of serous papillary type, whereas HNPCC-associated uterine cancers typically are of endometrial type, as in our case
[<xref ref-type="bibr" rid="B28">28</xref>]. Proven by loss of expression of MSH6 the EC in patient III:1 is due to the germline <italic>MSH6</italic> mutation. Additionally, the above mentioned higher rate of cervical cancers may be due to the interaction of the HPV oncogenes E6 and E7 with <italic>BRCA1</italic>, which has been shown to render the cervix more susceptible to cancer
[<xref ref-type="bibr" rid="B29">29</xref>].</p>
      <p>The incidence of ovarian cancer in HBOCS is higher than in Lynch Syndrome. Additionally, <italic>BRCA1</italic>-associated ovarian cancers often show high grade serous histology, whereas HNPCC-associated ovarian cancers often display endometrioid histology
[<xref ref-type="bibr" rid="B23">23</xref>,<xref ref-type="bibr" rid="B30">30</xref>]. Therefore, the ovarian cancer of individual II:5 was most probably <italic>BRCA1-</italic>associated.</p>
      <p>It can be assumed that revised Bethesda Guidelines recommendations for the identification of colorectal tumors that should be tested for MSI, sometimes fail to identify individuals with HNPCC. To avoid non-identification of HNPCC-patients it might be reasonable to screen both, colorectal and endometrial cancer tumor specimens for MMR-defect. Interestingly, this topic has been discussed at least for colorectal cancer at the HNPCC workshop conducted by the NCI in Bethesda, MD in 2002. Although participants voted to keep less than 60 years of age in the guideline 3 there was no consensus on whether to include the age criteria
[<xref ref-type="bibr" rid="B4">4</xref>].</p>
      <p>Data from the Robert Koch Institute German Cancer Registry (
<ext-link ext-link-type="uri" xlink:href="http://www.rki.de">http://www.rki.de</ext-link>) indicate that the incidence of HNPCC associated cancers such as colorectal, small bowel, urinary tract, and endometrial cancer is about 6% in the German population. Assuming that 5% of these tumors are caused by MMR gene mutations with a penetrance of 80%, the allele frequency in the German population is 0.38%
[<xref ref-type="bibr" rid="B31">31</xref>]. Incidence of breast cancer is 9.53% in the German female population. On the assumption that 5% of these tumors are caused by <italic>BRCA1</italic> or <italic>BRCA2</italic> mutations with a penetrance of 85% and that the allele frequency is similar in the male population, the allele frequency in the whole German population is 0.6%
[<xref ref-type="bibr" rid="B32">32</xref>,<xref ref-type="bibr" rid="B33">33</xref>]. Therefore, the probability to be a carrier of both mutations in breast cancer genes and MMR genes is 1/167 &#xD7; 1/260 &#xD7; 1/4 = 1/174.800, which sums up to 470 carriers of both alleles in the German population. Since allele frequencies are similar in Western populations the frequency of carriers of both alleles may be up to 5.7 per one million individuals.</p>
      <p>Although carriers of mutations in both MMR and BRCA genes are rare in Caucasian populations, anamnestical and histopathological findings may guide clinicians to identify these families. Firstly, meeting both Bethesda Guidelines and HBOCS Criteria may raise suspicion of both syndromes in one family. Secondly, this may be substantiated by specific histological findings in available tumors, such as triple negative breast cancers (<italic>BRCA1</italic>-associated), high grade papillary serous ovarian cancer (<italic>BRCA1</italic>- and <italic>2</italic>-associated), endometrioid cancer of the uterus (MMR-gene-associated) and microsatellite instability (MMR-gene-associated). Finally, both syndromes can only be diagnosed through a complete gene analysis of the respective genes.</p>
    </sec>
    <sec>
      <title>Consent</title>
      <p>Written informed consent was obtained from the index patient III:1 and from relative IV:5 for publication of this case report and any accompanying images.</p>
    </sec>
    <sec>
      <title>Misc</title>
      <p>Karin Kast and Teresa M Neuhann contributed equally to this work.</p>
    </sec>
    <sec>
      <title>Competing interests</title>
      <p>The authors declare that they have no competing interests.</p>
    </sec>
    <sec>
      <title>Authors' contributions</title>
      <p>Karin Kast worked on the concept and design of the study and wrote the manuscript, also contributing to the acquisition, analysis and interpretation of the data. Teresa Neuhann recruited the family, initiated the genetic diagnostics of the BRCA and HNPCC genes, suggested the publication of the case and contributed to the writing of the manuscript. Katja Keller, Kerstin Becker and Barbara Klink were involved in data acquisition and communication with the patients. Daniela Aust and Heike G&#xF6;rgens were fundamental for the analysis and interpretation of the data. Evelin Schr&#xF6;ck contributed to the final manuscript and oversaw the genetic counseling. Wolfgang Distler approved the manuscript to be published. Hans K. Schackert advised and contributed to the concept, design and writing the manuscript, as well as to the analysis and interpretation of data. All authors read and approved the final manuscript.</p>
    </sec>
    <sec>
      <title>Pre-publication history</title>
      <p>The pre-publication history for this paper can be accessed here:</p>
      <p>
        <ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2407/12/531/prepub">http://www.biomedcentral.com/1471-2407/12/531/prepub</ext-link>
      </p>
    </sec>
  </body>
  <back>
    <sec>
      <title>Acknowledgements</title>
      <p>Research support: German Cancer Aid (Deutsche Krebshilfe, grants no: 3641011021 and 108906). German Consortium of Hereditary Breast and Ovarian Cancer (GC-HBOC). German Consortium for Hereditary Colorectal Cancer. Patients of both databases.</p>
    </sec>
    <ref-list>
      <ref id="B1">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Antoniou</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Pharoah</surname>
            <given-names>PD</given-names>
          </name>
          <name>
            <surname>Narod</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Risch</surname>
            <given-names>HA</given-names>
          </name>
          <name>
            <surname>Eyfjord</surname>
            <given-names>JE</given-names>
          </name>
          <name>
            <surname>Hopper</surname>
            <given-names>JL</given-names>
          </name>
          <name>
            <surname>Loman</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Olsson</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Johannsson</surname>
            <given-names>O</given-names>
          </name>
          <name>
            <surname>Borg</surname>
            <given-names>A</given-names>
          </name>
          <etal/>
          <article-title>Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies</article-title>
          <source>Am J Hum Genet</source>
          <year>2003</year>
          <volume>72</volume>
          <issue>5</issue>
          <fpage>1117</fpage>
          <lpage>1130</lpage>
          <pub-id pub-id-type="doi">10.1086/375033</pub-id>
          <pub-id pub-id-type="pmid">12677558</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B2">
        <mixed-citation publication-type="journal">
          <name>
            <surname>King</surname>
            <given-names>MC</given-names>
          </name>
          <name>
            <surname>Marks</surname>
            <given-names>JH</given-names>
          </name>
          <name>
            <surname>Mandell</surname>
            <given-names>JB</given-names>
          </name>
          <article-title>Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2</article-title>
          <source>Science</source>
          <year>2003</year>
          <volume>302</volume>
          <issue>5645</issue>
          <fpage>643</fpage>
          <lpage>646</lpage>
          <pub-id pub-id-type="doi">10.1126/science.1088759</pub-id>
          <pub-id pub-id-type="pmid">14576434</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B3">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Lynch</surname>
            <given-names>HT</given-names>
          </name>
          <name>
            <surname>de la Chapelle</surname>
            <given-names>A</given-names>
          </name>
          <article-title>Hereditary colorectal cancer</article-title>
          <source>N Engl J Med</source>
          <year>2003</year>
          <volume>348</volume>
          <issue>10</issue>
          <fpage>919</fpage>
          <lpage>932</lpage>
          <pub-id pub-id-type="doi">10.1056/NEJMra012242</pub-id>
          <pub-id pub-id-type="pmid">12621137</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B4">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Umar</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Boland</surname>
            <given-names>CR</given-names>
          </name>
          <name>
            <surname>Terdiman</surname>
            <given-names>JP</given-names>
          </name>
          <name>
            <surname>Syngal</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>de la Chapelle</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Ruschoff</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Fishel</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Lindor</surname>
            <given-names>NM</given-names>
          </name>
          <name>
            <surname>Burgart</surname>
            <given-names>LJ</given-names>
          </name>
          <name>
            <surname>Hamelin</surname>
            <given-names>R</given-names>
          </name>
          <etal/>
          <article-title>Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability</article-title>
          <source>J Natl Cancer Inst</source>
          <year>2004</year>
          <volume>96</volume>
          <issue>4</issue>
          <fpage>261</fpage>
          <lpage>268</lpage>
          <pub-id pub-id-type="doi">10.1093/jnci/djh034</pub-id>
          <pub-id pub-id-type="pmid">14970275</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B5">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Aarnio</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Sankila</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Pukkala</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Salovaara</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Aaltonen</surname>
            <given-names>LA</given-names>
          </name>
          <name>
            <surname>de la Chapelle</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Peltomaki</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Mecklin</surname>
            <given-names>JP</given-names>
          </name>
          <name>
            <surname>Jarvinen</surname>
            <given-names>HJ</given-names>
          </name>
          <article-title>Cancer risk in mutation carriers of DNA-mismatch-repair genes</article-title>
          <source>Int J Cancer</source>
          <year>1999</year>
          <volume>81</volume>
          <issue>2</issue>
          <fpage>214</fpage>
          <lpage>218</lpage>
          <pub-id pub-id-type="doi">10.1002/(SICI)1097-0215(19990412)81:2&lt;214::AID-IJC8&gt;3.0.CO;2-L</pub-id>
          <pub-id pub-id-type="pmid">10188721</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B6">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Baglietto</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Lindor</surname>
            <given-names>NM</given-names>
          </name>
          <name>
            <surname>Dowty</surname>
            <given-names>JG</given-names>
          </name>
          <name>
            <surname>White</surname>
            <given-names>DM</given-names>
          </name>
          <name>
            <surname>Wagner</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Gomez Garcia</surname>
            <given-names>EB</given-names>
          </name>
          <name>
            <surname>Vriends</surname>
            <given-names>AH</given-names>
          </name>
          <name>
            <surname>Cartwright</surname>
            <given-names>NR</given-names>
          </name>
          <name>
            <surname>Barnetson</surname>
            <given-names>RA</given-names>
          </name>
          <name>
            <surname>Farrington</surname>
            <given-names>SM</given-names>
          </name>
          <etal/>
          <article-title>Risks of Lynch syndrome cancers for MSH6 mutation carriers</article-title>
          <source>J Natl Cancer Inst</source>
          <year>2010</year>
          <volume>102</volume>
          <issue>3</issue>
          <fpage>193</fpage>
          <lpage>201</lpage>
          <pub-id pub-id-type="doi">10.1093/jnci/djp473</pub-id>
          <pub-id pub-id-type="pmid">20028993</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B7">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Dunlop</surname>
            <given-names>MG</given-names>
          </name>
          <name>
            <surname>Farrington</surname>
            <given-names>SM</given-names>
          </name>
          <name>
            <surname>Carothers</surname>
            <given-names>AD</given-names>
          </name>
          <name>
            <surname>Wyllie</surname>
            <given-names>AH</given-names>
          </name>
          <name>
            <surname>Sharp</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Burn</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Kinzler</surname>
            <given-names>KW</given-names>
          </name>
          <name>
            <surname>Vogelstein</surname>
            <given-names>B</given-names>
          </name>
          <article-title>Cancer risk associated with germline DNA mismatch repair gene mutations</article-title>
          <source>Hum Mol Genet</source>
          <year>1997</year>
          <volume>6</volume>
          <issue>1</issue>
          <fpage>105</fpage>
          <lpage>110</lpage>
          <pub-id pub-id-type="doi">10.1093/hmg/6.1.105</pub-id>
          <pub-id pub-id-type="pmid">9002677</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B8">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Bonadona</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Bonaiti</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Olschwang</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Grandjouan</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Huiart</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Longy</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Guimbaud</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Buecher</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Bignon</surname>
            <given-names>YJ</given-names>
          </name>
          <name>
            <surname>Caron</surname>
            <given-names>O</given-names>
          </name>
          <etal/>
          <article-title>Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome</article-title>
          <source>JAMA</source>
          <year>2011</year>
          <volume>305</volume>
          <issue>22</issue>
          <fpage>2304</fpage>
          <lpage>2310</lpage>
          <pub-id pub-id-type="doi">10.1001/jama.2011.743</pub-id>
          <pub-id pub-id-type="pmid">21642682</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B9">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Plaschke</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Engel</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Kruger</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Holinski-Feder</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Pagenstecher</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Mangold</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Moeslein</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Schulmann</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Gebert</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>von Knebel Doeberitz</surname>
            <given-names>M</given-names>
          </name>
          <etal/>
          <article-title>Lower incidence of colorectal cancer and later age of disease onset in 27 families with pathogenic MSH6 germline mutations compared with families with MLH1 or MSH2 mutations: the German Hereditary Nonpolyposis Colorectal Cancer Consortium</article-title>
          <source>J Clin Oncol</source>
          <year>2004</year>
          <volume>22</volume>
          <issue>22</issue>
          <fpage>4486</fpage>
          <lpage>4494</lpage>
          <pub-id pub-id-type="doi">10.1200/JCO.2004.02.033</pub-id>
          <pub-id pub-id-type="pmid">15483016</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B10">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Rodriguez-Bigas</surname>
            <given-names>MA</given-names>
          </name>
          <name>
            <surname>Boland</surname>
            <given-names>CR</given-names>
          </name>
          <name>
            <surname>Hamilton</surname>
            <given-names>SR</given-names>
          </name>
          <name>
            <surname>Henson</surname>
            <given-names>DE</given-names>
          </name>
          <name>
            <surname>Jass</surname>
            <given-names>JR</given-names>
          </name>
          <name>
            <surname>Khan</surname>
            <given-names>PM</given-names>
          </name>
          <name>
            <surname>Lynch</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Perucho</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Smyrk</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Sobin</surname>
            <given-names>L</given-names>
          </name>
          <etal/>
          <article-title>A National Cancer Institute Workshop on Hereditary Nonpolyposis Colorectal Cancer Syndrome: meeting highlights and Bethesda guidelines</article-title>
          <source>J Natl Cancer Inst</source>
          <year>1997</year>
          <volume>89</volume>
          <issue>23</issue>
          <fpage>1758</fpage>
          <lpage>1762</lpage>
          <pub-id pub-id-type="doi">10.1093/jnci/89.23.1758</pub-id>
          <pub-id pub-id-type="pmid">9392616</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B11">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Meindl</surname>
            <given-names>A</given-names>
          </name>
          <collab>German Consortium for Hereditary Breast and Ovarian Cancer</collab>
          <article-title>Comprehensive analysis of 989 patients with breast or ovarian cancer provides BRCA1 and BRCA2 mutation profiles and frequencies for the German population</article-title>
          <source>Int J Cancer</source>
          <year>2002</year>
          <volume>97</volume>
          <issue>4</issue>
          <fpage>472</fpage>
          <lpage>480</lpage>
          <pub-id pub-id-type="pmid">11802209</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B12">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Hoffman</surname>
            <given-names>JD</given-names>
          </name>
          <name>
            <surname>Hallam</surname>
            <given-names>SE</given-names>
          </name>
          <name>
            <surname>Venne</surname>
            <given-names>VL</given-names>
          </name>
          <name>
            <surname>Lyon</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Ward</surname>
            <given-names>K</given-names>
          </name>
          <article-title>Implications of a novel cryptic splice site in the BRCA1 gene</article-title>
          <source>Am J Med Genet</source>
          <year>1998</year>
          <volume>80</volume>
          <issue>2</issue>
          <fpage>140</fpage>
          <lpage>144</lpage>
          <pub-id pub-id-type="doi">10.1002/(SICI)1096-8628(19981102)80:2&lt;140::AID-AJMG10&gt;3.0.CO;2-L</pub-id>
          <pub-id pub-id-type="pmid">9805131</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B13">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Plaschke</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Kruger</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Pistorius</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Theissig</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Saeger</surname>
            <given-names>HD</given-names>
          </name>
          <name>
            <surname>Schackert</surname>
            <given-names>HK</given-names>
          </name>
          <article-title>Involvement of hMSH6 in the development of hereditary and sporadic colorectal cancer revealed by immunostaining is based on germline mutations, but rarely on somatic inactivation</article-title>
          <source>Int J Cancer</source>
          <year>2002</year>
          <volume>97</volume>
          <issue>5</issue>
          <fpage>643</fpage>
          <lpage>648</lpage>
          <pub-id pub-id-type="doi">10.1002/ijc.10097</pub-id>
          <pub-id pub-id-type="pmid">11807791</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B14">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Plaschke</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Kruppa</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Tischler</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Bocker</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Pistorius</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Dralle</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Ruschoff</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Saeger</surname>
            <given-names>HD</given-names>
          </name>
          <name>
            <surname>Fishel</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Schackert</surname>
            <given-names>HK</given-names>
          </name>
          <article-title>Sequence analysis of the mismatch repair gene hMSH6 in the germline of patients with familial and sporadic colorectal cancer</article-title>
          <source>Int J Cancer</source>
          <year>2000</year>
          <volume>85</volume>
          <issue>5</issue>
          <fpage>606</fpage>
          <lpage>613</lpage>
          <pub-id pub-id-type="doi">10.1002/(SICI)1097-0215(20000301)85:5&lt;606::AID-IJC2&gt;3.0.CO;2-B</pub-id>
          <pub-id pub-id-type="pmid">10699937</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B15">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Engel</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Rahner</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Schulmann</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Holinski-Feder</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Goecke</surname>
            <given-names>TO</given-names>
          </name>
          <name>
            <surname>Schackert</surname>
            <given-names>HK</given-names>
          </name>
          <name>
            <surname>Kloor</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Steinke</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Vogelsang</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Moslein</surname>
            <given-names>G</given-names>
          </name>
          <etal/>
          <article-title>Efficacy of annual colonoscopic surveillance in individuals with hereditary nonpolyposis colorectal cancer</article-title>
          <source>Clin Gastroenterol Hepatol</source>
          <year>2010</year>
          <volume>8</volume>
          <issue>2</issue>
          <fpage>174</fpage>
          <lpage>182</lpage>
          <pub-id pub-id-type="doi">10.1016/j.cgh.2009.10.003</pub-id>
          <pub-id pub-id-type="pmid">19835992</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B16">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Borg</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Isola</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Rubio</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Johansson</surname>
            <given-names>U</given-names>
          </name>
          <name>
            <surname>Werelius</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Lindblom</surname>
            <given-names>A</given-names>
          </name>
          <article-title>Germline BRCA1 and HMLH1 mutations in a family with male and female breast carcinoma</article-title>
          <source>Int J Cancer</source>
          <year>2000</year>
          <volume>85</volume>
          <issue>6</issue>
          <fpage>796</fpage>
          <lpage>800</lpage>
          <pub-id pub-id-type="doi">10.1002/(SICI)1097-0215(20000315)85:6&lt;796::AID-IJC10&gt;3.0.CO;2-L</pub-id>
          <pub-id pub-id-type="pmid">10709098</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B17">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Thiffault</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Hamel</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Pal</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>McVety</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Marcus</surname>
            <given-names>VA</given-names>
          </name>
          <name>
            <surname>Farber</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Cowie</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Deschenes</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Meschino</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Odefrey</surname>
            <given-names>F</given-names>
          </name>
          <etal/>
          <article-title>Germline truncating mutations in both MSH2 and BRCA2 in a single kindred</article-title>
          <source>Br J Cancer</source>
          <year>2004</year>
          <volume>90</volume>
          <issue>2</issue>
          <fpage>483</fpage>
          <lpage>491</lpage>
          <pub-id pub-id-type="doi">10.1038/sj.bjc.6601424</pub-id>
          <pub-id pub-id-type="pmid">14735197</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B18">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Win</surname>
            <given-names>AK</given-names>
          </name>
          <name>
            <surname>Jenkins</surname>
            <given-names>MA</given-names>
          </name>
          <name>
            <surname>Buchanan</surname>
            <given-names>DD</given-names>
          </name>
          <name>
            <surname>Clendenning</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Young</surname>
            <given-names>JP</given-names>
          </name>
          <name>
            <surname>Giles</surname>
            <given-names>GG</given-names>
          </name>
          <name>
            <surname>Goldblatt</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Leggett</surname>
            <given-names>BA</given-names>
          </name>
          <name>
            <surname>Hopper</surname>
            <given-names>JL</given-names>
          </name>
          <name>
            <surname>Thibodeau</surname>
            <given-names>SN</given-names>
          </name>
          <etal/>
          <article-title>Determining the frequency of de novo germline mutations in DNA mismatch repair genes</article-title>
          <source>J Med Genet</source>
          <year>2011</year>
          <volume>48</volume>
          <issue>8</issue>
          <fpage>530</fpage>
          <lpage>534</lpage>
          <pub-id pub-id-type="doi">10.1136/jmedgenet-2011-100082</pub-id>
          <pub-id pub-id-type="pmid">21636617</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B19">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Buerki</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Gautier</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Kovac</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Marra</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Buser</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Mueller</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Heinimann</surname>
            <given-names>K</given-names>
          </name>
          <article-title>Evidence for breast cancer as an integral part of Lynch syndrome</article-title>
          <source>Genes Chromosomes Cancer</source>
          <year>2012</year>
          <volume>51</volume>
          <issue>1</issue>
          <fpage>83</fpage>
          <lpage>91</lpage>
          <pub-id pub-id-type="doi">10.1002/gcc.20935</pub-id>
          <pub-id pub-id-type="pmid">22034109</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B20">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Muller</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Edmonston</surname>
            <given-names>TB</given-names>
          </name>
          <name>
            <surname>Corao</surname>
            <given-names>DA</given-names>
          </name>
          <name>
            <surname>Rose</surname>
            <given-names>DG</given-names>
          </name>
          <name>
            <surname>Palazzo</surname>
            <given-names>JP</given-names>
          </name>
          <name>
            <surname>Becker</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Fry</surname>
            <given-names>RD</given-names>
          </name>
          <name>
            <surname>Rueschoff</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Fishel</surname>
            <given-names>R</given-names>
          </name>
          <article-title>Exclusion of breast cancer as an integral tumor of hereditary nonpolyposis colorectal cancer</article-title>
          <source>Cancer Res</source>
          <year>2002</year>
          <volume>62</volume>
          <issue>4</issue>
          <fpage>1014</fpage>
          <lpage>1019</lpage>
          <pub-id pub-id-type="pmid">11861375</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B21">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Shanley</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Fung</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Milliken</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Leary</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Barnetson</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Schnitzler</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Kirk</surname>
            <given-names>J</given-names>
          </name>
          <article-title>Breast cancer immunohistochemistry can be useful in triage of some HNPCC families</article-title>
          <source>Fam Cancer</source>
          <year>2009</year>
          <volume>8</volume>
          <issue>3</issue>
          <fpage>251</fpage>
          <lpage>255</lpage>
          <pub-id pub-id-type="doi">10.1007/s10689-008-9226-4</pub-id>
          <pub-id pub-id-type="pmid">19123071</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B22">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Walsh</surname>
            <given-names>MD</given-names>
          </name>
          <name>
            <surname>Buchanan</surname>
            <given-names>DD</given-names>
          </name>
          <name>
            <surname>Cummings</surname>
            <given-names>MC</given-names>
          </name>
          <name>
            <surname>Pearson</surname>
            <given-names>SA</given-names>
          </name>
          <name>
            <surname>Arnold</surname>
            <given-names>ST</given-names>
          </name>
          <name>
            <surname>Clendenning</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Walters</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>McKeone</surname>
            <given-names>DM</given-names>
          </name>
          <name>
            <surname>Spurdle</surname>
            <given-names>AB</given-names>
          </name>
          <name>
            <surname>Hopper</surname>
            <given-names>JL</given-names>
          </name>
          <etal/>
          <article-title>Lynch syndrome-associated breast cancers: clinicopathologic characteristics of a case series from the colon cancer family registry</article-title>
          <source>Clin Cancer Res</source>
          <year>2010</year>
          <volume>16</volume>
          <issue>7</issue>
          <fpage>2214</fpage>
          <lpage>2224</lpage>
          <pub-id pub-id-type="doi">10.1158/1078-0432.CCR-09-3058</pub-id>
          <pub-id pub-id-type="pmid">20215533</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B23">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Watson</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Vasen</surname>
            <given-names>HF</given-names>
          </name>
          <name>
            <surname>Mecklin</surname>
            <given-names>JP</given-names>
          </name>
          <name>
            <surname>Bernstein</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Aarnio</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Jarvinen</surname>
            <given-names>HJ</given-names>
          </name>
          <name>
            <surname>Myrhoj</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Sunde</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Wijnen</surname>
            <given-names>JT</given-names>
          </name>
          <name>
            <surname>Lynch</surname>
            <given-names>HT</given-names>
          </name>
          <article-title>The risk of extra-colonic, extra-endometrial cancer in the Lynch syndrome</article-title>
          <source>Int J Cancer</source>
          <year>2008</year>
          <volume>123</volume>
          <issue>2</issue>
          <fpage>444</fpage>
          <lpage>449</lpage>
          <pub-id pub-id-type="doi">10.1002/ijc.23508</pub-id>
          <pub-id pub-id-type="pmid">18398828</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B24">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Win</surname>
            <given-names>AK</given-names>
          </name>
          <name>
            <surname>Young</surname>
            <given-names>JP</given-names>
          </name>
          <name>
            <surname>Lindor</surname>
            <given-names>NM</given-names>
          </name>
          <name>
            <surname>Tucker</surname>
            <given-names>KM</given-names>
          </name>
          <name>
            <surname>Ahnen</surname>
            <given-names>DJ</given-names>
          </name>
          <name>
            <surname>Young</surname>
            <given-names>GP</given-names>
          </name>
          <name>
            <surname>Buchanan</surname>
            <given-names>DD</given-names>
          </name>
          <name>
            <surname>Clendenning</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Giles</surname>
            <given-names>GG</given-names>
          </name>
          <name>
            <surname>Winship</surname>
            <given-names>I</given-names>
          </name>
          <etal/>
          <article-title>Colorectal and other cancer risks for carriers and noncarriers from families with a DNA mismatch repair gene mutation: a prospective cohort study</article-title>
          <source>J Clin Oncol</source>
          <year>2012</year>
          <volume>30</volume>
          <issue>9</issue>
          <fpage>958</fpage>
          <lpage>964</lpage>
          <pub-id pub-id-type="doi">10.1200/JCO.2011.39.5590</pub-id>
          <pub-id pub-id-type="pmid">22331944</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B25">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Scott</surname>
            <given-names>RJ</given-names>
          </name>
          <name>
            <surname>McPhillips</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Meldrum</surname>
            <given-names>CJ</given-names>
          </name>
          <name>
            <surname>Fitzgerald</surname>
            <given-names>PE</given-names>
          </name>
          <name>
            <surname>Adams</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Spigelman</surname>
            <given-names>AD</given-names>
          </name>
          <name>
            <surname>du Sart</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Tucker</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Kirk</surname>
            <given-names>J</given-names>
          </name>
          <article-title>Hereditary nonpolyposis colorectal cancer in 95 families: differences and similarities between mutation-positive and mutation-negative kindreds</article-title>
          <source>Am J Hum Genet</source>
          <year>2001</year>
          <volume>68</volume>
          <issue>1</issue>
          <fpage>118</fpage>
          <lpage>127</lpage>
          <pub-id pub-id-type="doi">10.1086/316942</pub-id>
          <pub-id pub-id-type="pmid">11112663</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B26">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Atchley</surname>
            <given-names>DP</given-names>
          </name>
          <name>
            <surname>Albarracin</surname>
            <given-names>CT</given-names>
          </name>
          <name>
            <surname>Lopez</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Valero</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Amos</surname>
            <given-names>CI</given-names>
          </name>
          <name>
            <surname>Gonzalez-Angulo</surname>
            <given-names>AM</given-names>
          </name>
          <name>
            <surname>Hortobagyi</surname>
            <given-names>GN</given-names>
          </name>
          <name>
            <surname>Arun</surname>
            <given-names>BK</given-names>
          </name>
          <article-title>Clinical and pathologic characteristics of patients with BRCA-positive and BRCA-negative breast cancer</article-title>
          <source>J Clin Oncol</source>
          <year>2008</year>
          <volume>26</volume>
          <issue>26</issue>
          <fpage>4282</fpage>
          <lpage>4288</lpage>
          <pub-id pub-id-type="doi">10.1200/JCO.2008.16.6231</pub-id>
          <pub-id pub-id-type="pmid">18779615</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B27">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Thompson</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Easton</surname>
            <given-names>DF</given-names>
          </name>
          <article-title>Cancer Incidence in BRCA1 mutation carriers</article-title>
          <source>J Natl Cancer Inst</source>
          <year>2002</year>
          <volume>94</volume>
          <issue>18</issue>
          <fpage>1358</fpage>
          <lpage>1365</lpage>
          <pub-id pub-id-type="doi">10.1093/jnci/94.18.1358</pub-id>
          <pub-id pub-id-type="pmid">12237281</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B28">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Lavie</surname>
            <given-names>O</given-names>
          </name>
          <name>
            <surname>Ben-Arie</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Segev</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Faro</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Barak</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Haya</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Auslender</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Gemer</surname>
            <given-names>O</given-names>
          </name>
          <article-title>BRCA germline mutations in women with uterine serous carcinoma&#x2013;still a debate</article-title>
          <source>Int J Gynecol Cancer</source>
          <year>2010</year>
          <volume>20</volume>
          <issue>9</issue>
          <fpage>1531</fpage>
          <lpage>1534</lpage>
          <pub-id pub-id-type="pmid">21119368</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B29">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Zhang</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Fan</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Meng</surname>
            <given-names>Q</given-names>
          </name>
          <name>
            <surname>Ma</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Katiyar</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Schlegel</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Rosen</surname>
            <given-names>EM</given-names>
          </name>
          <article-title>BRCA1 interaction with human papillomavirus oncoproteins</article-title>
          <source>J Biol Chem</source>
          <year>2005</year>
          <volume>280</volume>
          <issue>39</issue>
          <fpage>33165</fpage>
          <lpage>33177</lpage>
          <pub-id pub-id-type="doi">10.1074/jbc.M505124200</pub-id>
          <pub-id pub-id-type="pmid">15983032</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B30">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Gilks</surname>
            <given-names>CB</given-names>
          </name>
          <name>
            <surname>Prat</surname>
            <given-names>J</given-names>
          </name>
          <article-title>Ovarian carcinoma pathology and genetics: recent advances</article-title>
          <source>Hum Pathol</source>
          <year>2009</year>
          <volume>40</volume>
          <issue>9</issue>
          <fpage>1213</fpage>
          <lpage>1223</lpage>
          <pub-id pub-id-type="doi">10.1016/j.humpath.2009.04.017</pub-id>
          <pub-id pub-id-type="pmid">19552940</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B31">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Lynch</surname>
            <given-names>HT</given-names>
          </name>
          <name>
            <surname>de la Chapelle</surname>
            <given-names>A</given-names>
          </name>
          <article-title>Genetic susceptibility to non-polyposis colorectal cancer</article-title>
          <source>J Med Genet</source>
          <year>1999</year>
          <volume>36</volume>
          <issue>11</issue>
          <fpage>801</fpage>
          <lpage>818</lpage>
          <pub-id pub-id-type="pmid">10544223</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B32">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Claus</surname>
            <given-names>EB</given-names>
          </name>
          <name>
            <surname>Schildkraut</surname>
            <given-names>JM</given-names>
          </name>
          <name>
            <surname>Thompson</surname>
            <given-names>WD</given-names>
          </name>
          <name>
            <surname>Risch</surname>
            <given-names>NJ</given-names>
          </name>
          <article-title>The genetic attributable risk of breast and ovarian cancer</article-title>
          <source>Cancer</source>
          <year>1996</year>
          <volume>77</volume>
          <issue>11</issue>
          <fpage>2318</fpage>
          <lpage>2324</lpage>
          <pub-id pub-id-type="doi">10.1002/(SICI)1097-0142(19960601)77:11&lt;2318::AID-CNCR21&gt;3.0.CO;2-Z</pub-id>
          <pub-id pub-id-type="pmid">8635102</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B33">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Narod</surname>
            <given-names>SA</given-names>
          </name>
          <name>
            <surname>Foulkes</surname>
            <given-names>WD</given-names>
          </name>
          <article-title>BRCA1 and BRCA2: 1994 and beyond</article-title>
          <source>Nat Rev Cancer</source>
          <year>2004</year>
          <volume>4</volume>
          <issue>9</issue>
          <fpage>665</fpage>
          <lpage>676</lpage>
          <pub-id pub-id-type="doi">10.1038/nrc1431</pub-id>
          <pub-id pub-id-type="pmid">15343273</pub-id>
        </mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
